Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Treatment
79 results:

  • 1. Kurarinone targets JAK2-STAT3 signaling in colon cancer-stem-like cells.
    Prajapati KS; Kumar S
    Cell Biochem Funct; 2024 Mar; 42(2):e3959. PubMed ID: 38390770
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inhibition of CSF1R and KIT With Pexidartinib Reduces Inflammatory Signaling and Cell Viability in Endometriosis.
    Dunn TN; Cope DI; Tang S; Sirupangi T; Parks SE; Liao Z; Yuan F; Creighton CJ; Masand RP; Alpuing Radilla L; Guan X; Detti L; Monsivais D; Matzuk MM
    Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38227801
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Overexpressing lipid raft protein STOML2 modulates the tumor microenvironment via NF-κB signaling in colorectal cancer.
    Gong H; Chen S; Liu S; Hu Q; Li Y; Li Y; Li G; Huang K; Li R; Fang L
    Cell Mol Life Sci; 2024 Jan; 81(1):39. PubMed ID: 38214751
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Bioinformatics analysis-based screening of circRNA gene with mainstream expression trend in colorectal cancer and construction of a coexpression regulatory network.
    Xu L; Zhang H; Shao Y; Fu Z
    PLoS One; 2023; 18(12):e0295126. PubMed ID: 38064496
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases.
    Wesdorp NJ; Zeeuw JM; Postma SCJ; Roor J; van Waesberghe JHTM; van den Bergh JE; Nota IM; Moos S; Kemna R; Vadakkumpadan F; Ambrozic C; van Dieren S; van Amerongen MJ; Chapelle T; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Marquering HA; Stoker J; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
    Eur Radiol Exp; 2023 Dec; 7(1):75. PubMed ID: 38038829
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
    Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
    BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Yiqi Huayu Jiedu Decoction inhibits liver metastasis of colorectal cancer via enhancing natural killer cells function.
    Zhou JY; Wu C; Shen Z; Liu S; Zou X; Qian J; Wu Z; Huan X; Mu BX; Ye N; Ning Y; Wang Y; Chen M; Zhuang Y
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116915. PubMed ID: 37451487
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors.
    Kim JY; Jung J; Kim KM; Lee J; Im YH
    Cancer Med; 2023 Jun; 12(11):12438-12451. PubMed ID: 37081749
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Metformin and thymoquinone co-treatment enhance 5-fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells.
    Farrash WF; Aslam A; Almaimani R; Minshawi F; Almasmoum H; Alsaegh A; Iqbal MS; Tabassum A; Elzubier ME; El-Readi MZ; Mahbub AA; Idris S; Refaat B
    Biofactors; 2023; 49(4):831-848. PubMed ID: 36929658
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
    Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
    Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in colorectal cancer.
    Mokgautsi N; Kuo YC; Chen CH; Huang YJ; Wu ATH; Huang HS
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672275
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Intra- and interobserver agreement of rectal cancer staging with MRI.
    Kilickap G; Dolek BA; Ercan K
    Acta Radiol; 2023 May; 64(5):1747-1754. PubMed ID: 36476121
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Studies on Chemical Composition of
    Fang X; Zhang Y; Cao Y; Shan M; Song D; Ye C; Zhu D
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364084
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction.
    Hassabo AA; Abdelraof M; Allam RM
    Int J Biol Macromol; 2023 Jan; 224():634-645. PubMed ID: 36302487
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With colorectal cancer.
    Moretz C; Byfield SD; Hatchell KE; Dalton J; Onglao PN; Hang L; Hansen P; Radford C; Nielsen SM; Heald B; Munro SB; Nussbaum RL; Esplin ED
    JAMA Netw Open; 2022 Oct; 5(10):e2238167. PubMed ID: 36279135
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells.
    Yadav P; Sharma P; Chetlangia N; Mayalagu P; Karunagaran D
    Chem Biol Interact; 2022 Dec; 368():110224. PubMed ID: 36272469
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Enhanced anti-cancer effects of oestrogen and progesterone co-therapy against colorectal cancer in males.
    Mahbub AA; Aslam A; Elzubier ME; El-Boshy M; Abdelghany AH; Ahmad J; Idris S; Almaimani R; Alsaegh A; El-Readi MZ; Baghdadi MA; Refaat B
    Front Endocrinol (Lausanne); 2022; 13():941834. PubMed ID: 36263327
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Additive Effect of CD73 Inhibitor in colorectal cancer treatment With CDK4/6 Inhibitor Through Regulation of PD-L1.
    Noh JY; Lee IP; Han NR; Kim M; Min YK; Lee SY; Yun SH; Kim SI; Park T; Chung H; Park D; Lee CH
    Cell Mol Gastroenterol Hepatol; 2022; 14(4):769-788. PubMed ID: 35843546
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre study.
    Qi LN; Ma L; Wu FX; Chen YY; Xu JX; Peng YC; Chen ZS; Gong WF; Yang CL; Wei HW; Qin SL; Shang JJ; Wang QY; Yu HP; Peng T; Huang YW; Ling YC; Tang WZ; Xiang BD; Li LQ
    Liver Int; 2022 Oct; 42(10):2283-2298. PubMed ID: 35810457
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of hub genes and pathways in colitis-associated colon cancer by integrated bioinformatic analysis.
    Huang Y; Zhang X; PengWang ; Li Y; Yao J
    BMC Genom Data; 2022 Jun; 23(1):48. PubMed ID: 35733095
    [TBL] [Abstract] [Full Text] [Related]  


    of 4.